Medicenna Therapeutics Corp. logo
Medicenna Therapeutics Corp. MDNA
$ 0.16 -13.16%

Quarterly report 2022-Q1
added 06-22-2022

report update icon

Medicenna Therapeutics Corp. Market Cap 2011-2025 | MDNA

As of November 05, 2025 Medicenna Therapeutics Corp. has a market cap of $ 7.95 M


Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]

Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.

This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.

Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.

Annual Market Cap Medicenna Therapeutics Corp.

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
49.7 M - - - - - - - - - -
202120212020202020192019201820182017201720162016201520152014201420132013201220122011201150 M50 M40 M40 M30 M30 M20 M20 M10 M10 M00
Download SVG
Download PNG
Download CSV

All numbers in CAD currency

Indicator range from annual reports

Maximum Minimum Average
49.7 M 49.7 M 49.7 M

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.